Forward PE Ratio: 25.34
The forward PE ratio is 25.34 as of Thursday, July 9, 2026.
Forward PE Ratio (25.34) = Close Price ($377.13) / Consensus Forward EPS ($14.53)
WAT Forward PE Ratio Metrics
FORWARD PE RATIO
25.34
WAT Competitors' Forward PE Ratio
Waters Corporation
Market Cap
$24.58B
Forward PE Ratio
25.34
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Waters Corporation (WAT) | $24.58B | 25.34 |
| West Pharmaceutical Services, Inc. (WST)vs › | $25.27B | 41.06 |
| Incyte Corporation (INCY)vs › | $23.68B | 15.33 |
| BioNTech SE (BNTX)vs › | $23.51B | N/A |
| United Therapeutics Corporation (UTHR)vs › | $23.45B | 19.75 |
| Mettler-Toledo International Inc. (MTD)vs › | $26.03B | 26.75 |
| Quest Diagnostics Incorporated (DGX)vs › | $23.03B | 19.37 |
| Labcorp Holdings Inc. (LH)vs › | $22.77B | 15.42 |
| STERIS plc (STE)vs › | $21.05B | 20.54 |
| DexCom, Inc. (DXCM)vs › | $28.18B | 28.55 |
Trailing vs Forward
Trailing P/E
46.8
reported TTM EPS
Forward P/E
25.3
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $14.53 implies +84.6% EPS growth vs the reported trailing $7.87.
Forward P/E by Fiscal Year
View All Analyst EstimatesAt today's $377.13 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $14.53 | $14.46 – $14.58 | 13 | 26.0x |
| 2027-12-31 | $16.46 | $16.11 – $17.48 | 13 | 22.9x |
| 2028-12-31 | $18.29 | $14.61 – $22.41 | 5 | 20.6x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
Forward PE Ratio Formula & Definition
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Forward PE Ratio FAQ
- What is the forward PE ratio for Waters Corporation (WAT)?
- The forward PE ratio for WAT stock is 25.34.
Related Metrics
About Waters Corporation
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Udit Batra